Human iPSC-derived neurons reveal early developmental alteration of neurite outgrowth in the late-occurring neurodegenerative Wolfram syndrome

Am J Hum Genet. 2021 Nov 4;108(11):2171-2185. doi: 10.1016/j.ajhg.2021.10.001. Epub 2021 Oct 25.

Abstract

Recent studies indicate that neurodegenerative processes that appear during childhood and adolescence in individuals with Wolfram syndrome (WS) occur in addition to early brain development alteration, which is clinically silent. Underlying pathological mechanisms are still unknown. We have used induced pluripotent stem cell-derived neural cells from individuals affected by WS in order to reveal their phenotypic and molecular correlates. We have observed that a subpopulation of Wolfram neurons displayed aberrant neurite outgrowth associated with altered expression of axon guidance genes. Selective inhibition of the ATF6α arm of the unfolded protein response prevented the altered phenotype, although acute endoplasmic reticulum stress response-which is activated in late Wolfram degenerative processes-was not detected. Among the drugs currently tried in individuals with WS, valproic acid was the one that prevented the pathological phenotypes. These results suggest that early defects in axon guidance may contribute to the loss of neurons in individuals with WS.

Keywords: Wolfram syndrome; axon guidance; endoplasmic reticulum stress; induced pluripotent stem cells; neurite outgrowth; neurodegenerative disease; neurodevelopmental disease; neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset*
  • CRISPR-Cas Systems
  • Case-Control Studies
  • Endoplasmic Reticulum Stress
  • Gene Expression Regulation
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Neurites* / drug effects
  • Neurons / cytology*
  • Valproic Acid / pharmacology
  • Wolfram Syndrome / genetics
  • Wolfram Syndrome / pathology*

Substances

  • Valproic Acid